Exelixis
EXEL
#1694
Rank
A$15.66 B
Marketcap
$54.84
Share price
-3.83%
Change (1 day)
57.41%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: $77.86 AUD on 2000-07-26

Lowest end of day price: $2.04 AUD on 2014-12-24

Stock price history of Exelixis from 2000 to 2024

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$54.12 1.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
$77.37 6.65%๐Ÿ‡ซ๐Ÿ‡ท France
$158.19 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$91.14 3.19%๐Ÿ‡บ๐Ÿ‡ธ USA
$420.46-0.21%๐Ÿ‡บ๐Ÿ‡ธ USA
$231.47 1.78%๐Ÿ‡บ๐Ÿ‡ธ USA
$41.79 4.67%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.45-0.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$23.71 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA